DELCATH NEWS
Press Releases
August 21, 2008
DELCATH
EXPANDS PHASE III TRIAL FOR METASTATIC MELANOMA
August 12, 2008
Delcath
Expands Phase III Trial for Metastatic Melanoma
to Include John Wayne Cancer Institute in California
August 7, 2008
Delcath
Systems to Present at the 28th Annual Canaccord
Adams Global Growth Conference
July 24, 2008
DELCATH
EXPANDS PHASE III TRIAL FOR METASTATIC MELANOMA
TO FLORIDA
July 17, 2008
Delcath
Systems Announces Clinical and Regulatory Appointments
July 15, 2008
Delcath
Systems' Targeted Drug Delivery System for Liver
Cancer Treatment to Be Featured on FOX Business
News
June 24, 2008
DELCATH
EXPANDS MULTI-CENTER PHASE III TRIAL FOR METASTATIC
MELANOMA
June 18, 2008
Delcath
Adds Atlantic Health to Phase III Trial for
Metastatic Melanoma
June 4, 2008
Delcath
Announces Expanded Clinical Initiatives at Annual
Meeting Today
June 4, 2008
Delcath
Adds the Cancer Center of Albany Medical Center
to Phase III Trial for Metastatic Melanoma
June 3, 2008
Delcath
Expands Phase III Trial for Metastatic Melanoma
to Include St. Luke's Cancer Center
May 20, 2008
Delcath
Updates Phase III Patient Enrollment as Pivotal
Trial Accelerates, Durable Tumor Responses In
Phase II Study Also Cited
May 13, 2008
Delcath
To Present at the Rodman & Renshaw 5th Annual
Global Healthcare Conference
April 25, 2008
DELCATH
EXPANDS PHASE III TRIAL FOR METASTATIC MELANOMA
TO INCLUDE UNIVERSITY OF MARYLAND MEDICAL CENTER
March 31, 2008
Delcath
Systems Presents Positive Phase II Data on Delcath
PHP System in Treatment of Inoperable Liver
Metastases
February 13, 2008
DELCATH
SYSTEMS TO HOST CONFERENCE CALL TO PROVIDE CORPORATE
UPDATE
January 30, 2008
Delcath and Aethlon Medical Sign Collaboration
Agreement to Research and Develop Advanced Filtration
Technology
January 24, 2008
Delcath
System Gains Significant Exposure Through Presentations
at Several Prominent Scientific Meetings
January 3, 2008
Delcath
Appoints Three Leading Physicians to Its Newly
Formed Scientific Advisory Board
November 29, 2007
Delcath
Granted Japanese Patent for Delcath System
November 20, 2007
Delcath
Resumes Enrollment in Phase III and Phase II
Trials
October 23, 2007
Delcath
Voluntarily Defers Accrual in Clinical Trials
October 18, 2007
Delcath Systems Technology Profiled in European
Medical Technology Publication
October 11, 2007
Delcath
Treatment for Liver Cancer is ''Featured Clinical
Trial'' in Latest National Cancer Institute
(NCI) Cancer Bulletin
October 4, 2007
Delcath
Systems Issues CEO Letter to Shareholders
September 26, 2007
Delcath
Announces Closing of $14.2 Million Investment
by Institutional Investors Proceeds To Fund
Completion of Phase III Trial for the Treatment
of Liver Cancer
September 24, 2007
Delcath
to Present at the 12th Annual Drug Delivery
Technologies
& Deal Making Conference
September 18, 2007
Delcath
Systems, Inc. Raises $14.2 Million in Private
Offering
September 18, 2007
Delcath
to Present at the CL King Best Ideas Conference
September 17, 2007
Delcath
to Present at the ThinkEquity Partners' 5th
Annual Growth Conference
August 20, 2007
SAMUEL
HERSCHKOWITZ, M.D. RESIGNS AS DIRECTOR OF DELCATH
August 2, 2007
Delcath
to Present at the Canaccord Adams Global Growth
Conference
July 27, 2007
Delcath
to Present at the ThinkBIG
2007 Conference Sponsored by ThinkEquity Partners
LLC
June 28, 2007
DELCATH
TO PRESENT AT THE THIRD ANNUAL
C.E. UNTERBERG, TOWBIN EMERGING GROWTH CONFERENCE
June 26, 2007
Delcath
Expands Phase II Multi-Histology Clinical Trial
New Arm to Treat Relapsed Melanoma Patients
Previously Shown to Respond to Isolated Hepatic
Perfusion
June 13, 2007
Delcath
Fulfills Nasdaq Independent Director and Audit
Committee Requirements With Addition of Two
New Directors
June 5, 2007
Delcath
Updates Clinical Trials
June 5, 2007
Jonathan
J. Lewis, MD Joins Delcath's Board of Directors
May 30, 2007
Delcath
Systems Receives National Cancer Institute Approval
to Expand Phase III Trial to Multiple Center
May 24, 2007
Delcath Systems Names Laura A. Philips to Board
of Directors
May 24, 2007
Delcath
Systems Adds Two Executives
May 17, 2007
Delcath
Systems Announces Presentation of Data at World
Conference on Interventional Oncology
May 16, 2007
Delcath
Systems Issues CEO Letter to Shareholders
February
9, 2007
Delcath
Systems Retains Former Director of Operations
as Advisor
February
2, 2007
Delcath
Elects Dr. Harold Koplewicz Chairman of the
Board of Directors
Delcath Settles Litigation Against Former Director
of Operations
January
26, 2007
Delcath
Announces the Resignation of M. S. Koly as Chairman
of the Board of Directors
January 4, 2007
Delcath
Appoints Dr. Samuel Herschkowitz as Interim
COO
|
